Impact of STAT3 Inhibition on Survival of Osteosarcoma Cell Lines

被引:1
|
作者
Wang, Xiaochun [1 ,2 ]
Goldstein, David [3 ]
Crowe, Philip J. [2 ,3 ]
Yang, Jia-Lin [1 ,2 ]
机构
[1] Univ New S Wales, Sarcoma Res Grp, Adult Canc Program, Lowy Canc Res Ctr,Prince Wales Clin Sch,Fac Med, Randwick, NSW, Australia
[2] Univ New S Wales, Fac Med, Dept Surg, Prince Wales Clin Sch, Randwick, NSW, Australia
[3] Univ New S Wales, Fac Med, Dept Med Oncol, Prince Wales Clin Sch, Randwick, NSW, Australia
关键词
Osteosarcoma; STAT3; S3I-201; PROSTATE-CANCER CELLS; SIGNAL TRANSDUCER; CONSTITUTIVE ACTIVATION; HEPATOCELLULAR-CARCINOMA; SUPPRESSES GROWTH; SMALL-MOLECULE; MYELOMA CELLS; CYCLE ARREST; LUNG-CANCER; NSC; 74859;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Osteosarcoma is often a fatal malignancy. Constitutive STAT3 activation is associated with various human cancers and commonly suggests poor prognosis. We aimed to investigate the effect and potential molecular mechanisms of STAT3 inhibition on osteosarcoma. Materials and Methods: STAT3 inhibitor S3I-201 was investigated in six osteosarcoma cell lines. Crystal violet colorimetric, clonogenic, cleaved caspase-3 assays and western blot were performed to measure the effect and mechanisms of STAT3 inhibition. Results: All osteosarcoma cell lines expressed phosphorylated STAT3. Anti-proliferative effects of S3I-201 were dose- and time-dependent. S3I-201 also inhibited colony-formation and induced apoptosis through the caspase cleavage pathway. Finally, molecular mechanism studies suggested that down-regulation of STAT3 phosphorylation and downstream STAT3-target genes such as cyclin D1 and survivin may contribute to S3I-201-mediated anti-proliferation and apoptosis. Conclusion: Inhibition of STAT3 signalling suppressed osteosarcoma cell growth and induced apoptosis, and indicated that STAT3 targeted-therapy may have therapeutic potential in osteosarcoma.
引用
收藏
页码:6537 / 6545
页数:9
相关论文
共 50 条
  • [1] SiRNA mediated inhibition of STAT3 in human pancreatic cancer cell lines
    Glienke, W.
    Hausmann, E.
    Bergmann, L.
    [J]. ONKOLOGIE, 2010, 33 : 24 - 24
  • [2] Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
    Stacey L Fossey
    Misty D Bear
    William C Kisseberth
    Michael Pennell
    Cheryl A London
    [J]. BMC Cancer, 11
  • [3] Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
    Fossey, Stacey L.
    Bear, Misty D.
    Kisseberth, William C.
    Pennell, Michael
    London, Cheryl A.
    [J]. BMC CANCER, 2011, 11
  • [4] Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma
    Tornin, Juan
    Mateu-Sanz, Miguel
    Rey, Veronica
    Murillo, Dzohara
    Huergo, Carmen
    Gallego, Borja
    Rodriguez, Aida
    Rodriguez, Rene
    Canal, Cristina
    [J]. REDOX BIOLOGY, 2023, 62
  • [5] MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines
    A Vultur
    J Villanueva
    C Krepler
    G Rajan
    Q Chen
    M Xiao
    L Li
    P A Gimotty
    M Wilson
    J Hayden
    F Keeney
    K L Nathanson
    M Herlyn
    [J]. Oncogene, 2014, 33 : 1850 - 1861
  • [6] MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines
    Vultur, A.
    Villanueva, J.
    Krepler, C.
    Rajan, G.
    Chen, Q.
    Xiao, M.
    Li, L.
    Gimotty, P. A.
    Wilson, M.
    Hayden, J.
    Keeney, F.
    Nathanson, K. L.
    Herlyn, M.
    [J]. ONCOGENE, 2014, 33 (14) : 1850 - 1861
  • [7] The role of STAT1 in tumor killing effect induced by STAT3 inhibition in HNSCC cell lines
    Shim, Seon-Hui
    Park, Seok-Woo
    Sung, Myung-Whun
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [8] Role of STAT3 in pediatric sarcoma cell lines
    Hariharan, Seethalakshmi
    Phelps, Doris A.
    Houghton, Peter J.
    [J]. CANCER RESEARCH, 2016, 76
  • [9] STAT3 is constitutively activated in Hodgkin cell lines
    Kube, D
    Holtick, U
    Vockerodt, M
    Ahmadi, T
    Haier, B
    Behrmann, I
    Heinrich, PC
    Diehl, V
    Tesch, H
    [J]. BLOOD, 2001, 98 (03) : 762 - 770
  • [10] Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3
    Tu, Bing
    Zhu, Jing
    Liu, Shen
    Wang, Lei
    Fan, Qiming
    Hao, Yongqiang
    Fan, Cunyi
    Tang, Ting-Ting
    [J]. ONCOTARGET, 2016, 7 (30) : 48296 - 48308